Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Leukemia, Myeloid × Sensitivity and Specificity × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 3 Lymphoma, Mantle-Cell 3 Lymphoma, Large B-Cell, Diffuse 3 Lymphoma, Follicular 3 Leukemia, Prolymphocytic, B-Cell 3 Leukemia, Lymphocytic, Chronic, B-Cell 3 Leukemia, Myeloid, Acute 2 Study of Risk Factors for IPMNs Degeneration at the Nancy CHRU 1 Stomach Neoplasms 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Pancreatic Neoplasms 1 Multiple Myeloma 1 Lymphoma, T-Cell 1 Lymphoma, Extranodal NK-T-Cell 1 Leukemia, Prolymphocytic, T-Cell 1 Leukemia, Myeloid 1 Leukemia, Large Granular Lymphocytic 1 Immunoblastic Lymphadenopathy 1 Enteropathy-Associated T-Cell Lymphoma 1 Colorectal Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma, Hepatocellular 1

Interventions

Cytarabine 12 fludarabine 11 venetoclax 9 Imatinib Mesylate 8 Cyclophosphamide 8 Busulfan 7 Whole-Body Irradiation 6 Tacrolimus 6 Mycophenolic Acid 6 Azacitidine 6 fludarabine phosphate 5 thymoglobulin 4 ponatinib 4 Sirolimus 4 Peripheral Blood Stem Cell Transplantation 4 nilotinib 3 aldesleukin 3 Methotrexate 3 Melphalan 3 Interleukin-2 3 Granulocyte Colony-Stimulating Factor 3 Decitabine 3 Bone Marrow Transplantation 3 Antilymphocyte Serum 3 zosuquidar trihydrochloride 2 gilteritinib 2 enasidenib 2 bosutinib 2 asciminib 2 Thiotepa 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01864902 2016-01-28

CART33

Chinese PLA General Hospital

Phase 1/2 Unknown

Other hematologic neoplasm

Leukemia, Myeloid

Data powered by HemOnc (CC BY 4.0) Colophon ⚡